Costing data for intensive care admissions is important, not only for unit funding, but also for cost outcome analysis of new therapies. This paper presents an intensive care episode costing methodology using the example of a cost-benefit analysis of mask CPAP for severe cardiogenic pulmonary oedema (CPO). This analysis examines the intervention of admitling all patients with severe CPO to the intensive care unit for mask CPAp, compared with the previous practice of admitting only patients failing conventional non-CPAP treatment and requiring mechanical ventilation.
Intensive Care Units (ICUs) have grown in size and number, with considerable economic consequences. In the United States, ICUs account for 7!Ifo of hospital beds and 20-30!Ifo of hospital costs. I In our situation for the period 1990-1991 the Intensive Care Unit consumed 3.6!Ifo of total hospital expenditure, or 4.8!Ifo of total inpatient expenditure. Health care resources are limited and all clinicians are accountable for appropriate utilisation of these resources. 2 Therefore, the evaluation of a new health care intervention following demonstration of efficacy involves the assessment of efficiency or cost-effectiveness. 3 The acquisition of accurate costing data for critical illnesses requiring ICU admission will be important, not only for unit funding, but also for cost outcome analyses for new ICU therapies such as mask continuous positive airway pressure (CPAP) for severe cardiogenic pulmonary oedema.
Severe CPO is a frequent cause of acute respiratory failure. Treatment has included oxygen, vasodilators, diuretics, morphine and inotropic agents. Most patients respond slowly to this medical therapy over several hours and are often observed in the accident and emergency department during this period prior to transfer to a coronary care unit or ward. However, some patients fail to improve and require mechanical ventilation. Prior to the introduction of mask CPAP for severe CPO, there were approximately 35 such patients per year requiring mechanical ventilation admitted to the ICU at Flinders Medical Centre.
The delivery of CPAP via a tight-fitting facemask for the treatment of severe CPO was first described more than fifty years ago.' However, the precise role of mask CPAP in these patients was previously poorly defined. In a prospective, randomised study we have shown that oxygen delivered via mask CPAP (the mechanical efficiency of the system is likely to be important)' increases the rate of physiological improvement when compared with oxygen therapy alone and results in a significant reduction in the need for intubation and mechanical ventilation (O!Ifo vs 35!Ifo) in patients with CPG. 6 Only patients who remained hypoxaemic in spite of 8 litres/minute of oxygen via a Hudson facemask following frusemide and nitrates were entered into this study. Unfortunately, this study was not able to identify predictive indices that allowed the early recognition of patients who would require mechanical ventilation. Subsequently, mask CPAP has been widely used in all patients with severe CPO who have not responded to the administration of oxygen, nitrates and diuretics. This change in practice has resulted in a substantial increase in the number of patients with severe CPO admitted to our ICU. Now, approximately 100 patients per year are admitted for mask CPAP therapy, compared with 35 patients previously requiring mechanical ventilation. Admitting patients for mask CPAP to decrease the likelihood of mechanical ventilation has obvious cost implications for the ICU.
We undertook this cost-benefit analysis to contribute to the overall evaluation of mask CPAP therapy in patients with severe cpo.
METHODS
A methodology for costing ICU admissions has been recently developed by the South Australian Intensive Care Costing and Casemix Study Group (National Case Mix Development Programme). The costs have been partitioned into categories within the ICU cost centre, other cost centres and hospital overhead costs. This costing study was undertaken between January and September 1991, and costs reflect wages, salaries and prices at that time. Length of stay data are based on the actual number of hours spent in ICU.
Nursing Salaries and Wages
Direct timing studies were performed to determine the number of nursing hours of direct care per day for a given patient. Indirect ICU nursing staff costs were apportioned across all patients surveyed on the basis of ICU length of stay. However, the cost associated with activities by ICU staff out of ICU (e.g. ICU equipment nurse, time spent in other wards) was excluded, as was the time spent by senior nursing staff on non-inpatient activities such as research and education/development.
Medical Salaries and Wages
The ICU medical staff during the study period included four consultants, registrar cover 24 hours a day, and junior residents from 0700 to 1900 hours each day. Direct medical practitioner time and therefore medical salary cqst per patient day varies significantly throughout a patient episode. The day of admission often demands considerable time spent with a patient and thereafter severity of illness is only one of a number of factors dictating the time spent. Time spent discussing cases between ICU and non-ICU practitioners, reviewing investigations and counselling relatives is variable and difficult to quantify. It was considered impractical, and not necessarily relevant, to undertake direct timing studies encompassing all these components of medical input. In the absence of such data, consultant, registrar and resident salary costs were apportioned across all patients on the basis of length of stay. Consultant costs included on-call allowance and recall payments. Costs relating to time spent on non-ICU and non-inpatient activities were excluded.
Drug Supplies
All drugs consumed by each patient were identified. The unit cost for a drug included costs of on-site hospital pharmacy preparation and additional consumables for drug infusion.
Medical and Surgical Consumables
Individual consumable items for each procedure were identified and costed. All procedures performed on patients were recorded and a derived consumable cost assigned. An initial day cost covering insertion and commencement, followed by a daily maintenance cost of monitoring techniques and therapies, was estimated.
Other Costs
These included all other costs assigned to the ICU cost centre, and consisted of clerical salaries, linen, domestic supplies, stationery and equipment maintenance. This was apportioned on the basis of length of stay.
Allied Health Departments
Actual time spent with each patient by allied health staff was recorded. Time taken on associated tasks such as record keeping was also recorded. A cost per patient was derived using total time and actual salary rates.
Pathology
Details of actual tests for each patient were extracted from the centre's computerised laboratory results system and costed using the consolidated Commonwealth Medical Benefits Schedule (November 1991). While Commonwealth Medical Benefits Schedule may not be ideal, and likely to result in an overestimation of costs in the setting of a public hospital, alternative costing data from laboratory tests were not available to the costing team.
Radiology
All radiological investigations for each patient were recorded and costs assigned to patients using results from a previous internal radiology costing study. The methodology used to determine individual investigation costs have been described previously.-
Hospital Overhead Costs
Costs associated with the provision of services to ICU patients, but not costed directly to the ICU cost centre, include centralised services such as administration, electricity, piped gases, cleaning, etc. The proportion of their costs relating to ICU for the sample period was derived using the Yale Cost Model' and apportioned on the basis of length of stay.
This costing methodology was applied to outcome data from the prospective study of 39 patients with severe CPG." Patients were randomly assigned to either oxygen alone or oxygen plus CPAP delivered through a facemask. The outcome data ( Table 1) were used to estimate the overall cost per annum imolved in treating these patients with and without CPAP. A recent review of ICU admissions confirms the estimate of approximately 100 patients per annum admitted with severe CPG. 
RESULTS

Nursing Salaries and Wages
Direct timing studies found that the CPAP and nonventilated oxygen-only treated patients required IS nursing hours per 24 hours. Even though these patients required intensive nursing, there was relatively rapid physiological improvement, and by six hours the improved condition of both groups enabled reduced nursing intensity and reduced patient to nurse ratios. In contrast, patients who needed mechanical ventilation required 30 nursing hours per 24 hours. The ventilated patients needed constant one-to-one nursing with additional input for supervision, endotracheal suction, physiotherapy and pressure care by nursing team leaders. The average nursing hourly rate incorporating overtime penalties, relief and annual leave loading was $16.70 per hour. The additional cost attributed to senior and equipment nursing staff was $19.70 per patient per day.
Medical Salaries and Wages
The daily cost for residents and registrars was $48.20 and consultants $8S.82 per patient per day.
Drug Supplies
The unit costs of all drugs used in these patients are shown in Table 2 . Glyceryl trinitrate infusion was the most commonly used drug, with the day 1 cost made up of drug-$24.00, glass bottle containing S070 dextrose-$6.70 and infusion pump cassette-$IO.S0. The subsequent day cost only includes drug and infusion solution. Patients who required ventilation had a much higher drug usage (Table 3) , whereas oxygen-alone patients who were not ventilated had similar drug usage to the CPAP patients. 
Medical and Surgical Consumables
The initial day cost of the CPAP circuit ($26.00) is based upon an average component reusage (mask, CPAP valve and head strap) of three times. Subsequent days of CPAP only attract the minor additional cost of humidification ($3.80 per day). This compares with $0.50 for an oxygen facemask in the oxygen-alone group. Ventilation added surprisingly little in consumable costs: intubation ($6.40), daily suction ($8.20) and humidification. Intra-arterial pressure monitoring was the only other procedure undertaken in CPAP patients (42070) and non-ventilated oxygen-alone patients (23070). In contrast, the ventilated patients required more frequent and extensive range of procedures (Table 4 ). 
Other Costs
The combined cost of these miscellaneous items is $34.50 per day per patient.
Allied Health Departments
In this study patients' allied health expenditure was confined to physiotherapy costs on the ventilated patients. The average physiotherapy time per patient was 20 minutes per day, resulting in a daily cost of $4.68 per patient.
Pathology
Investigations per ICU episode are shown in Table 5 . 
Radiology
Mobile chest x-rays in the ICU have been costed at $32.00 per film. All patients had admission and thereafter daily chest x-rays.
Hospital Overhead Costs
These costs amounted to $323.00 per patient per day. The average total ICU episode cost and the various components are shown in Table 6 . The previous caseload of 35 ventilated patients with severe CPO per year prior to the introduction CPAP resulted in a yearly estimated expenditure of $176,925.
In comparison, our current practice with a predicted caseload of 100 patients with severe CPO requiring CPAP will result in a yearly estimated expenditure of only $115,600.
DISCUSSION
Intensive care units are expensive. Consequently, intensive care practitioners are increasingly being challenged to balance costs, benefits and possible detriments in patient care. The management of patients with respiratory failure from CPO at our institution has markedly changed following the conclusion of our prospective randomised study which showed that mask CPAP resulted in earlier improvement and reduced need for mechanical ventilation. The early application of mask CPAP in patients not responding to medical therapy (nitrates, frusemide and morphine) has resulted in a substantial increase in admissions to our intensive care unit. Although the overall workload has increased, the advantages of rapid relief of patient distress and the avoidance of mechanical ventilation have been gratifying.
This analysis has shown that the increase in ICU admissions was not associated with an increase in overall cost, but rather a significant saving. This cost analysis was confined to an ICU episode cost. However, the inclusion of ward costs could only increase projected savings. Under the previous admission criteria of only admitting patients to ICU who required ventilation, 65070 of patients with severe CPO were managed in the medical wards; ward resource utilisation, ward days and total hospital costs would have to be added to our estimate of non-CPAP treatment.
Whether the benefits of mask CPAP treatment can be achieved out of the ICU environment has not been demonstrated. Non-invasive ventilatory support is being increasingly used in many clinical situations, including the patient's home environment. However, patients with severe CPO treated by mask CPAP require careful nursing and monitoring. Experienced and appropriately trained medical staff must be immediately available. Patients accept the tight-fitting mask because of the rapid relief of symptoms, although the initial application in hypercapnoeic and hypoxaemic patients requires constant attention and encouragement. In our hands, the complications of this technique have been rare and confined to some superficial nasal bridge skin necrosis with prolonged use. However, the risk of airway obstruction, gastric distension and aspiration in patients with deteriorating conscious state remains. Furthermore, the failure of CPAP, although very infrequent, constitutes a medical emergency. The procedure of intubation and mechanical ventilation in these circumstances is hazardous. CPAP treatment is only part of the overall management strategy that is of benefit. Other components, such as intravenous glyceryl trinitrate and intra-arterial pressure monitoring, are more readily employed in the ICU setting.
The mean duration of CPAP administration was 9.3 ± 4.9 hours. It may be possible to shorten the ICU stay from the 1.2 ± 0.4 days in this study, but it would be logistically inconvenient and the saving minor.
Major contributiors to episode costs were nursing and medical salaries and hospital overheads. These are predominantly a function of the length of stay. Contributing disease processes or severity of illness had minimal independent impact. Severity of illness increases cost mostly via increasing the length of stay or nursing intensity rather than the cost of increased technology. Mechanical ventilation and invasive monitoring is itself a relatively minor contributor. Accordingly, strategies such as noninvasive respiratory support measures, aimed at minimising ICU stay without compromising patient outcome, are the most cost-effective.
As non-invasive ventilatory support techniques become demonstrably effective, it is important that hospitals are adequately reimbursed for their use. Output-based funding has been criticised for failing to equitably reimburse hospitals for intensive care patients! In an effort to change this, the latest version of disease classification systems (ICD-9CM, October 1991) included codes for mechanical ventilation via endotracheal or tracheostomy tubes. However, noninvasive techniques of respiratory support were excluded from these codes. The Australian National DRG grouper was developed from this disease classification for the purpose of providing a patient classification system consistent with Australian clinical practice. It is important to understand, especially in view of Australia's health funding moving towards an output-based system, that all patients admitted to ICU with severe respiratory failure are resource expensive regardless of therapy. The subsequent coding and reimbursement should encourage therapies of proven cost-benefit. We believe noninvasive techniques should be recognised along with mechanical ventilation through its inclusion in ICD-9CM procedure codes, as both will be markers of ICU resource utilisation.
